| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/28/2022 | 35.99% | Keefe, Bruyette & Woods | $67 → $45 | Downgrades | Outperform → Market Perform |
| 07/11/2022 | 84.35% | Piper Sandler | $72 → $61 | Maintains | Overweight |
| 07/07/2022 | 39.01% | Raymond James | $70 → $46 | Downgrades | Strong Buy → Outperform |
| 10/28/2021 | 111.54% | Raymond James | $63 → $70 | Maintains | Strong Buy |
| 04/28/2021 | 105.5% | Raymond James | $48 → $68 | Maintains | Strong Buy |
| 01/28/2021 | 45.06% | Raymond James | $42 → $48 | Maintains | Strong Buy |
| 11/16/2020 | 26.93% | Raymond James | $33 → $42 | Maintains | Strong Buy |
| 10/29/2020 | -15.38% | Piper Sandler | $24 → $28 | Maintains | Overweight |
| 10/29/2020 | -0.27% | Keefe, Bruyette & Woods | $28 → $33 | Upgrades | Market Perform → Outperform |
| 04/24/2020 | -24.45% | B. Riley Securities | $34 → $25 | Maintains | Buy |
| 04/23/2020 | -27.47% | Piper Sandler | $25 → $24 | Maintains | Overweight |
| 04/23/2020 | -24.45% | Raymond James | $30 → $25 | Maintains | Strong Buy |
| 04/13/2020 | -24.45% | Piper Sandler | $36 → $25 | Maintains | Overweight |
| 03/30/2020 | 2.75% | B. Riley Securities | $43 → $34 | Maintains | Buy |
| 01/30/2020 | 29.95% | B. Riley Securities | $42 → $43 | Maintains | Buy |
| 01/09/2020 | 26.93% | B. Riley Securities | $40 → $42 | Maintains | Buy |
| 10/25/2019 | 20.88% | B. Riley Securities | $38 → $40 | Maintains | Buy |
| 10/25/2019 | 23.9% | Raymond James | $38 → $41 | Maintains | Strong Buy |
| 04/26/2019 | -0.27% | B. Riley Securities | $25 → $33 | Upgrades | Neutral → Buy |
| 10/15/2018 | 11.82% | Raymond James | $36.67 → $37 | Maintains | Strong Buy |
| 09/17/2018 | 232.43% | Raymond James | $120 → $110 | Maintains | Strong Buy |
| 09/13/2018 | 171.99% | B. Riley Securities | $100 → $90 | Maintains | Neutral |
| 06/21/2018 | 298.91% | B. Riley Securities | $135 → $132 | Maintains | Buy |
| 01/31/2018 | 277.76% | B. Riley Securities | $120 → $125 | Maintains | Buy |
| 10/31/2017 | — | FBR Capital | Upgrades | Neutral → Buy | |
| 07/28/2017 | — | FBR Capital | Downgrades | Outperform → Market Perform |
Pathward Financial Questions & Answers
The latest price target for Pathward Financial (NASDAQ: CASH) was reported by Keefe, Bruyette & Woods on July 28, 2022. The analyst firm set a price target for $45.00 expecting CASH to rise to within 12 months (a possible 35.99% upside). 4 analyst firms have reported ratings in the last year.
The latest analyst rating for Pathward Financial (NASDAQ: CASH) was provided by Keefe, Bruyette & Woods, and Pathward Financial downgraded their market perform rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pathward Financial, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pathward Financial was filed on July 28, 2022 so you should expect the next rating to be made available sometime around July 28, 2023.
While ratings are subjective and will change, the latest Pathward Financial (CASH) rating was a downgraded with a price target of $67.00 to $45.00. The current price Pathward Financial (CASH) is trading at is $33.09, which is out of the analyst's predicted range.